欧洲儿童抗磷脂综合征诊断与治疗循证推荐:SHARE倡议
儿童抗磷脂综合征(APS)罕见且缺乏循证指南,SHARE倡议按EULAR标准操作流程系统检索文献(1473篇,15篇有效),由儿童风湿科与血液科专家制定4条诊断推荐、8条治疗推荐(含儿童灾难性APS)及2条APS母亲所生儿童推荐,并指出证据等级与推荐强度较低。
要点
- 建议制定儿童APS新分类标准,儿童起病SLE应筛查抗磷脂抗体以识别APS。
- 治疗推荐涵盖血栓事件预防及静脉和/或动脉血栓事件的治疗。
- 因儿童APS研究匮乏,推荐证据等级与强度相对较低。
核心结论
- SHARE倡议提供了儿童APS诊断与治疗的国际循证推荐,旨在促进诊疗改善与统一。
研究设计与样本
- 按EULAR标准操作流程,系统文献检索后由儿童风湿科与儿童血液科专家委员会制定推荐。
主要发现
- 文献检索获得1473篇文章,其中15篇有效且相关。
- 共接受4条诊断推荐和8条治疗推荐(包括儿童灾难性APS)。
- 另接受2条针对APS母亲所生儿童的推荐。
关键数值与推荐
- 同意有必要制定儿童APS新分类标准。
- 儿童起病系统性红斑狼疮相关APS应通过抗磷脂抗体筛查识别。
- 治疗推荐包括预防血栓事件以及静脉和/或动脉血栓事件的治疗。
- 因儿童APS研究匮乏,推荐证据等级和强度相对较低。
临床怎么用
- 临床可参照SHARE推荐统一儿童APS诊断与治疗路径。
- 对儿童起病SLE应进行抗磷脂抗体筛查以识别合并APS。
局限性
- 儿童APS研究稀少,推荐证据等级与强度相对较低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Antiphospholipid syndrome (APS) is rare in children, and evidence-based guidelines are sparse. Consequently, management is mostly based on observational studies and physician's experience, and treatment regimens differ widely. The Single Hub and Access point for paediatric Rheumatology in Europe (SHARE) initiative was launched to develop diagnostic and management regimens for children and young adults with rheumatic diseases. Here, we developed evidence-based recommendations for diagnosis and treatment of paediatric APS. Evidence-based recommendations were developed using the European League Against Rheumatism standard operating procedure. Following a detailed systematic review of the literature, a committee of paediatric rheumatologists and representation of paediatric haematology with expertise in paediatric APS developed recommendations. The literature review yielded 1473 articles, of which 15 were valid and relevant. In total, four recommendations for diagnosis and eight for treatment of paediatric APS (including paediatric Catastrophic Antiphospholipid Syndrome) were accepted. Additionally, two recommendations for children born to mothers with APS were accepted. It was agreed that new classification criteria for paediatric APS are necessary, and APS in association with childhood-onset systemic lupus erythematosus should be identified by performing antiphospholipid antibody screening. Treatment recommendations included prevention of thrombotic events, and treatment recommendations for venous and/or arterial thrombotic events. Notably, due to the paucity of studies on paediatric APS, level of evidence and strength of the recommendations is relatively low. The SHARE initiative provides international, evidence-based recommendations for diagnosis and treatment for paediatric APS, facilitating improvement and uniformity of care.
引用
- Groot N, de Graeff N, Avcin T, et al. European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiative. Ann Rheum Dis. 2017. PMID: 28473426. doi:10.1136/annrheumdis-2016-211001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。